USD 18.2
(-5.41%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 1.45 Billion USD | -2.33% |
2022 | 1.47 Billion USD | 3.39% |
2021 | 1.42 Billion USD | 23.18% |
2020 | 1.15 Billion USD | -23.46% |
2019 | 1.51 Billion USD | -5.54% |
2018 | 1.6 Billion USD | -1.2% |
2017 | 1.62 Billion USD | 1.26% |
2016 | 1.6 Billion USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 358 Million USD | 6.58% |
2024 Q2 | 329.9 Million USD | -7.85% |
2024 Q3 | 317.3 Million USD | -3.82% |
2023 FY | 1.44 Billion USD | -2.33% |
2023 Q3 | 363.3 Million USD | -4.04% |
2023 Q2 | 378.6 Million USD | 4.38% |
2023 Q1 | 362.7 Million USD | -0.96% |
2023 Q4 | 335.9 Million USD | -7.54% |
2022 FY | 1.47 Billion USD | 3.39% |
2022 Q4 | 366.2 Million USD | 0.41% |
2022 Q3 | 364.7 Million USD | -3.19% |
2022 Q2 | 376.7 Million USD | 0.7% |
2022 Q1 | 374.1 Million USD | 9.0% |
2021 Q2 | 411.9 Million USD | 3.67% |
2021 FY | 1.42 Billion USD | 23.18% |
2021 Q3 | 356.3 Million USD | -13.5% |
2021 Q1 | 397.3 Million USD | 2.27% |
2021 Q4 | 343.2 Million USD | -3.68% |
2020 Q3 | 340.7 Million USD | 126.38% |
2020 Q4 | 388.5 Million USD | 14.03% |
2020 FY | 1.15 Billion USD | -23.46% |
2020 Q1 | 278.4 Million USD | -28.51% |
2020 Q2 | 150.5 Million USD | -45.94% |
2019 Q2 | 393.6 Million USD | 8.4% |
2019 FY | 1.51 Billion USD | -5.54% |
2019 Q3 | 367 Million USD | -6.76% |
2019 Q1 | 363.1 Million USD | -14.0% |
2019 Q4 | 389.4 Million USD | 6.1% |
2018 Q3 | 380.9 Million USD | -10.0% |
2018 Q1 | 375.5 Million USD | 0.0% |
2018 Q2 | 423.2 Million USD | 12.7% |
2018 Q4 | 422.2 Million USD | 10.84% |
2018 FY | 1.6 Billion USD | -1.2% |
2017 FY | 1.62 Billion USD | 1.26% |
2016 FY | 1.6 Billion USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alcon Inc. | 5.6 Billion USD | 74.135% |
AptarGroup, Inc. | 1.26 Billion USD | -14.809% |
Baxter International Inc. | 4.97 Billion USD | 70.844% |
Becton, Dickinson and Company | 9.15 Billion USD | 84.153% |
Bausch + Lomb Corporation | 2.5 Billion USD | 42.073% |
Haemonetics Corporation | 676.53 Million USD | -114.401% |
ResMed Inc. | 2.6 Billion USD | 44.399% |
Teleflex Incorporated | 1.64 Billion USD | 11.927% |
Warby Parker Inc. | 365.22 Million USD | -297.154% |
West Pharmaceutical Services, Inc. | 1.12 Billion USD | -28.454% |